Oscar Health, Inc. ("Oscar" or the "Company") (NYSE: OSCR), a leading healthcare technology company, announced today certain ...

Ahead of the company’s second-quarter earnings call Aug. 6, Oscar Health is slashing its full-year guidance by about half a ...

Oscar Health (NYSE:OSCR) stock fell 3.5% after the healthcare technology company revised its 2025 financial guidance following a review of second quarter Marketplace data that revealed ...

Oscar Health (NYSE:OSCR) cut its full-year income outlook and posted preliminary second quarter results below Wall Street ...

The health insurance agency said Tuesday it now expects a medical loss ratio of 86% to 87% for the full year, with total revenue now seen at $12 billion to $12.2 billion and a loss from operations of ...

Investing.com -- Oscar Health has increased its full-year revenue forecast to between $12 billion and $12.2 billion, up from its previous guidance of $11.20 billion to $11.30 billion. This new outlook ...

Oscar Health (OSCR) shares rose 7% premarket on Tuesday after the company revised its full-year sales outlook.

The company announced that it now expects a loss from operations of approximately $230 million and a net loss of roughly $228 ...

As Erik Menendez and brother Lyle Menendez await a parole hearing, lawyer Mark Geragos shared that Erik, 54, is battling a ...

Short-term stock returns are largely driven by the perception of near-term earnings per share. Read more here.

The Platform section — which has elevated names like Barry Jenkins, Pietro Marcello, William Oldroyd, and Darius Marder — ...

President Donald Trump has deflected questions over the Justice Department's decision to interview Jeffrey Epstein's former ...